These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 31066995)
21. Bioinspired self-healing injectable nanocomposite hydrogels based on oxidized dextran and gelatin for growth-factor-free bone regeneration. Ma W; Yang M; Wu C; Wang S; Du M Int J Biol Macromol; 2023 Nov; 251():126145. PubMed ID: 37544566 [TBL] [Abstract][Full Text] [Related]
22. Abaloparatide Exerts Bone Anabolic Effects with Less Stimulation of Bone Resorption-Related Factors: A Comparison with Teriparatide. Makino A; Takagi H; Takahashi Y; Hase N; Sugiyama H; Yamana K; Kobayashi T Calcif Tissue Int; 2018 Sep; 103(3):289-297. PubMed ID: 29725706 [TBL] [Abstract][Full Text] [Related]
23. GelMA-collagen blends enable drop-on-demand 3D printablility and promote angiogenesis. Stratesteffen H; Köpf M; Kreimendahl F; Blaeser A; Jockenhoevel S; Fischer H Biofabrication; 2017 Sep; 9(4):045002. PubMed ID: 28795951 [TBL] [Abstract][Full Text] [Related]
24. Stiffness modification of photopolymerizable gelatin-methacrylate hydrogels influences endothelial differentiation of human mesenchymal stem cells. Lin CH; Su JJ; Lee SY; Lin YM J Tissue Eng Regen Med; 2018 Oct; 12(10):2099-2111. PubMed ID: 30058281 [TBL] [Abstract][Full Text] [Related]
25. Cell-laden interpenetrating network hydrogels formed from methacrylated gelatin and silk fibroin via a combination of sonication and photocrosslinking approaches. Xiao W; Li J; Qu X; Wang L; Tan Y; Li K; Li H; Yue X; Li B; Liao X Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():57-67. PubMed ID: 30889731 [TBL] [Abstract][Full Text] [Related]
26. Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics. Chen FM; Zhao YM; Sun HH; Jin T; Wang QT; Zhou W; Wu ZF; Jin Y J Control Release; 2007 Mar; 118(1):65-77. PubMed ID: 17250921 [TBL] [Abstract][Full Text] [Related]
27. Injectable hydrogel composite containing modified gold nanoparticles: implication in bone tissue regeneration. Lee D; Heo DN; Nah HR; Lee SJ; Ko WK; Lee JS; Moon HJ; Bang JB; Hwang YS; Reis RL; Kwon IK Int J Nanomedicine; 2018; 13():7019-7031. PubMed ID: 30464456 [TBL] [Abstract][Full Text] [Related]
28. Abaloparatide: Review of a Next-Generation Parathyroid Hormone Agonist. Boyce EG; Mai Y; Pham C Ann Pharmacother; 2018 May; 52(5):462-472. PubMed ID: 29241341 [TBL] [Abstract][Full Text] [Related]
29. A pH/ROS-responsive antioxidative and antimicrobial GelMA hydrogel for on-demand drug delivery and enhanced osteogenic differentiation in vitro. Qi H; Wang B; Wang M; Xie H; Chen C Int J Pharm; 2024 May; 657():124134. PubMed ID: 38643810 [TBL] [Abstract][Full Text] [Related]
30. ZIF-8 modified multifunctional injectable photopolymerizable GelMA hydrogel for the treatment of periodontitis. Liu Y; Li T; Sun M; Cheng Z; Jia W; Jiao K; Wang S; Jiang K; Yang Y; Dai Z; Liu L; Liu G; Luo Y Acta Biomater; 2022 Jul; 146():37-48. PubMed ID: 35364317 [TBL] [Abstract][Full Text] [Related]
31. Antibacterial sequential growth factor delivery from alginate/gelatin methacryloyl microspheres for bone regeneration. Dai M; Lin X; Hua P; Wang S; Sun X; Tang C; Zhang C; Liu L Int J Biol Macromol; 2024 Aug; 275(Pt 1):133557. PubMed ID: 38955293 [TBL] [Abstract][Full Text] [Related]
32. Controlled release of simvastatin from in situ forming hydrogel triggers bone formation in MC3T3-E1 cells. Park YS; David AE; Park KM; Lin CY; Than KD; Lee K; Park JB; Jo I; Park KD; Yang VC AAPS J; 2013 Apr; 15(2):367-76. PubMed ID: 23250670 [TBL] [Abstract][Full Text] [Related]
33. Thiol-ene Hydrogels for Local Delivery of PTH for Bone Regeneration in Critical Size defects. Wojda SJ; Marozas IA; Anseth KS; Yaszemski MJ; Donahue SW J Orthop Res; 2020 Mar; 38(3):536-544. PubMed ID: 31709588 [TBL] [Abstract][Full Text] [Related]
34. Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE) confirms that abaloparatide is a valuable addition to the armamentarium against osteoporosis. Reginster JY; Al Daghri NM; Bruyere O Expert Opin Pharmacother; 2017 Dec; 18(17):1811-1813. PubMed ID: 29048260 [TBL] [Abstract][Full Text] [Related]
35. Encapsulation of simvastatin in PLGA microspheres loaded into hydrogel loaded BCP porous spongy scaffold as a controlled drug delivery system for bone tissue regeneration. Nath SD; Linh NT; Sadiasa A; Lee BT J Biomater Appl; 2014 Apr; 28(8):1151-63. PubMed ID: 24029488 [TBL] [Abstract][Full Text] [Related]
36. Gelatin methacrylate scaffold for bone tissue engineering: The influence of polymer concentration. Celikkin N; Mastrogiacomo S; Jaroszewicz J; Walboomers XF; Swieszkowski W J Biomed Mater Res A; 2018 Jan; 106(1):201-209. PubMed ID: 28884519 [TBL] [Abstract][Full Text] [Related]
37. Abaloparatide: A review of preclinical and clinical studies. Brent MB Eur J Pharmacol; 2021 Oct; 909():174409. PubMed ID: 34364879 [TBL] [Abstract][Full Text] [Related]
38. Abaloparatide for the treatment of postmenopausal osteoporosis. Pietrogrande L; Raimondo E Drugs Today (Barc); 2018 May; 54(5):293-303. PubMed ID: 29911694 [TBL] [Abstract][Full Text] [Related]
39. A Pyk2 inhibitor incorporated into a PEGDA-gelatin hydrogel promotes osteoblast activity and mineral deposition. Posritong S; Flores Chavez R; Chu TG; Bruzzaniti A Biomed Mater; 2019 Feb; 14(2):025015. PubMed ID: 30658347 [TBL] [Abstract][Full Text] [Related]
40. Controlled release of simvastatin-loaded thermo-sensitive PLGA-PEG-PLGA hydrogel for bone tissue regeneration: in vitro and in vivo characteristics. Yan Q; Xiao LQ; Tan L; Sun W; Wu T; Chen LW; Mei Y; Shi B J Biomed Mater Res A; 2015 Nov; 103(11):3580-9. PubMed ID: 25969423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]